Malignant neoplasm of breast
|
0.310 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Malignant Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
Mutation analysis of HDAC1, HDAC2, SUV39H1, and SUV39H2 revealed only two out of 181 cancer samples (both cell lines) with significant coding-sequence alterations.
|
16638127 |
2006 |
Primary malignant neoplasm
|
0.040 |
Biomarker
|
group |
BEFREE |
Mutation analysis of HDAC1, HDAC2, SUV39H1, and SUV39H2 revealed only two out of 181 cancer samples (both cell lines) with significant coding-sequence alterations.
|
16638127 |
2006 |
Malignant neoplasm of lung
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
This study provided the first evidence that a novel SUV39H2 polymorphism may be an important predictive marker for lung cancer susceptibility for the smokers.
|
16774942 |
2006 |
Carcinoma of lung
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
This study provided the first evidence that a novel SUV39H2 polymorphism may be an important predictive marker for lung cancer susceptibility for the smokers.
|
16774942 |
2006 |
Primary malignant neoplasm of lung
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
This study provided the first evidence that a novel SUV39H2 polymorphism may be an important predictive marker for lung cancer susceptibility for the smokers.
|
16774942 |
2006 |
Lung Neoplasms
|
0.010 |
GeneticVariation
|
group |
LHGDN |
Novel polymorphisms in the SUV39H2 histone methyltransferase and the risk of lung cancer.
|
16774942 |
2006 |
Malignant neoplasm of lung
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Previously, we reported that a novel polymorphism of SUV39H2, the HMT that is required for the methylation of H3-K9, was associated with an increased risk of lung cancer in Koreans.
|
17693662 |
2007 |
Carcinoma of lung
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Previously, we reported that a novel polymorphism of SUV39H2, the HMT that is required for the methylation of H3-K9, was associated with an increased risk of lung cancer in Koreans.
|
17693662 |
2007 |
Primary malignant neoplasm of lung
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Previously, we reported that a novel polymorphism of SUV39H2, the HMT that is required for the methylation of H3-K9, was associated with an increased risk of lung cancer in Koreans.
|
17693662 |
2007 |
Diabetes Mellitus, Insulin-Dependent
|
0.010 |
Biomarker
|
disease |
BEFREE |
In this study, we investigated genetic polymorphisms of the SETD7, SUV39H1, and SUV39H2 methyltransferases as predictors of risk for micro- and macrovascular complications in type 1 diabetes.
|
21896933 |
2011 |
Pemphigus Vulgaris
|
0.010 |
Biomarker
|
disease |
BEFREE |
These changes were accompanied by increased HDAC1, HDAC2 and SUV39H2 and decreased SUV39H1 and EZH2 in PV PBMCs.
|
22512277 |
2012 |
Migraine Disorders
|
0.100 |
GeneticVariation
|
group |
GWASDB |
Genome-wide meta-analysis identifies new susceptibility loci for migraine.
|
23793025 |
2013 |
Migraine Disorders
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Genome-wide meta-analysis identifies new susceptibility loci for migraine.
|
23793025 |
2013 |
Systemic Scleroderma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Expression of JHDM2A was significantly increased but HDAC2, HDAC7, and, SUV39H2 were significantly down-regulated in SSc B cells relative to controls.
|
23891737 |
2013 |
Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
We further restricted the analysis only in tumor tissues, we found EZH2 staining intensity associated with tumor stage (p=0.016) and survival (p=0.007); SUV39H2 intensity associated with tumor stage (p=0.044).
|
24966962 |
2014 |
Liver carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Our findings indicate overexpression of histone-modifying genes EZH2 and SUV39H2 associated with prognosis of HCC cases.
|
24966962 |
2014 |
Hepatitis C
|
0.010 |
Biomarker
|
disease |
BEFREE |
Staining intensity of SUV39H2 correlated with HCV infection (p=0.025).
|
24966962 |
2014 |
Congenital chromosomal disease
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Conversely, high expression of SUV39H2 correlated with cytogenetic abnormalities in CLL patients.
|
28833505 |
2017 |
Chronic Lymphocytic Leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Conversely, high expression of SUV39H2 correlated with cytogenetic abnormalities in CLL patients.
|
28833505 |
2017 |
Latent Autoimmune Diabetes in Adults
|
0.010 |
Biomarker
|
disease |
BEFREE |
Reduced Histone H3 Lysine 9 Methylation Contributes to the Pathogenesis of Latent Autoimmune Diabetes in Adults via Regulation of SUV39H2 and KDM4C.
|
28396876 |
2017 |
Latent autoimmune diabetes mellitus in adult
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The expression of histone methyltransferase SUV39H2 for H3 lysine 9 methylation was downregulated in LADA patients, and the expression of histone demethylase KDM4C which made H3 lysine 9 demethylation was upregulated.<i>Conclusion</i>.
|
28396876 |
2017 |
Steatohepatitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Therefore, our data support a role of Suv39h2 in promoting steatosis in mice likely through contributing to SIRT1 trans-reperssion.
|
28232186 |
2017 |
Nonalcoholic Steatohepatitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
The histone methyltransferase Suv39h2 contributes to nonalcoholic steatohepatitis in mice.
|
28244120 |
2017 |
Malignant Neoplasms
|
0.050 |
AlteredExpression
|
group |
BEFREE |
Dysregulation of SUV39H2 expression has been observed in several types of cancers.
|
30348215 |
2018 |